Introduction to the special issue on medical imaging in oncology

Journal of Clinical Oncology

Volumn 24, Issue 20, 2006, Pages 3223-3224

  Hillman, Bruce J ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE; TUMOR MARKER;

CANCER DIAGNOSIS; CLINICAL RESEARCH; EDITORIAL; HUMAN; MEDICAL PRACTICE; MOLECULAR IMAGING; ONCOLOGY; PRIORITY JOURNAL; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; METHODOLOGY; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RADIOGRAPHY;

HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL; ULTRASONOGRAPHY;

EID: 33745937769     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.06.6076     Document Type: Editorial

References (4)

1. Thrall JH: ACR primer on molecular imaging. J Amer Coll Radiol 1:32, 2004
2. Hillman BJ, Neiman HL: Translating molecular imaging research into radiological practice: Proceedings of the American College of Radiology Colloquium. Radiology 222:19-24, 2002
3. Hillman BJ, Amis ES, Weinreb JC, et al: The future of imaging screening: Proceedings of the Fourth Annual ACR FORUM. J Am Coll Radiol 2:43-50, 2005
4. US Food and Drug Administration: Challenge and Opportunity on the Critical Path to New Medical Products. Washington, DC, Department of Health and Human Services, 2005